Semaglutide vial is a glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. This pharmaceutical intermediate has demonstrated significant effects on glycemic control and weight management in clinical research.
The semaglutide vial we supply contains lyophilized powder with purity exceeding 99% by HPLC analysis. Each vial is carefully packaged to maintain stability and comes with complete analytical documentation including COA, MSDS and HPLC reports.
Our semaglutide vial is produced under strict GMP conditions and undergoes rigorous quality control testing. The product is intended solely for research purposes and not for human consumption. Researchers can utilize this compound for studying metabolic disorders, diabetes mechanisms, and obesity-related conditions.
For laboratory use only. Not for diagnostic or therapeutic applications. Proper handling procedures should be followed when working with this peptide compound.